Advertisement
Product › Details
antibody technology
Next higher product group | drug discovery technology | |
Record changed: 2024-04-07 |
Advertisement
More documents for antibody technology
- [1] Biotalys N.V.. (4/24/23). "Press Release: Syngenta and Biotalys Enter into Strategic Partnership in Biologicals Innovation to Advance Solutions for Sustainable Agriculture". Basel & Ghent....
- [2] Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam....
- [3] Synaffix B.V.. (1/4/23). "Press Release: Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program". Amsterdam, San Francisco, CA, et al.....
- [4] Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen....
- [5] Biotalys N.V.. (10/20/21). "Press Release: Biotalys Awarded Multi-Year Grant to Develop New Biological Solutions for Cowpea and Other Legumes". Ghent & Research Triangle Park, NC....
- [6] Biotalys N.V.. (9/30/21). "Press Release: Biotalys Strengthens Executive Team with the Appointment of Patrick McDonnell as Chief Business Officer". Ghent & Research Triangle Park, NC....
- [7] ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium....
- [8] Atbtherapeutics. (12/1/20). "Press Release: Atbtherapeutics Initiates Agreement with iBio CDMO to Manufacture Game-changer atbodies to Better Treat Cancer". Marche-en-Famenne....
- [9] Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent....
- [10] ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top